H. Lee Moffitt Cancer Center and Research Institute
With
Florida Biomedical Research Program - Bankhead Coley
While this is a multi-level intervention study, only information related to the patient-level intervention is being reported for the purposes ClinicalTrials.gov.
Age
45–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants must be receiving care at one of the participating FQHC clinics.
Participants must be 45-75 years of age.
Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
Participants must never have had Hepatitis C Virus (HCV) antibody screening.
Participants must be able to read, write, and understand English or Spanish.
Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
Participants must be asymptomatic for HCV.
Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
Participants completing qualitative interviews must be willing to be audio recorded.
Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
All Participants must be able to provide informed consent.
You may not be if
Participants that do not meet all Inclusion Eligibility requirements will be excluded.
Clareo Health | Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
